Hemochromatosis (he-moe-kroe-muh-TOE-sis) causes your body to absorb too much iron from the food you eat. Excess iron is stored in your organs, especially your liver, heart and pancreas. Too much iron can lead to life-threatening conditions, such as liver disease, heart problems and diabetes.

There are a few types of hemochromatosis, but the most common type is caused by a gene change passed down through families. Only a few people who have the genes ever develop serious problems. Symptoms usually appear in midlife.

Treatment includes regularly removing blood from your body. Because much of the body's iron is contained in red blood cells, this treatment lowers iron levels.


Some people with hemochromatosis never have symptoms. Early symptoms often overlap with those of other common conditions.

Symptoms may include:

  • Joint pain.
  • Abdominal pain.
  • Fatigue.
  • Weakness.
  • Diabetes.
  • Loss of sex drive.
  • Impotence.
  • Heart failure.
  • Liver failure.
  • Bronze or gray skin color.
  • Memory fog.

When symptoms typically appear

The most common type of hemochromatosis is present at birth. But most people don't experience symptoms until later in life — usually after age 40 in men and after age 60 in women. Women are more likely to develop symptoms after menopause, when they no longer lose iron with menstruation and pregnancy.

When to see a doctor

See your health care provider if you experience any of the symptoms of hemochromatosis. If you have an immediate family member who has hemochromatosis, ask your provider about genetic testing. Genetic testing can check if you have the gene that increases your risk of hemochromatosis.

From Mayo Clinic to your inbox

Sign up for free and stay up to date on research advancements, health tips, current health topics, and expertise on managing health. Click here for an email preview.

To provide you with the most relevant and helpful information, and understand which information is beneficial, we may combine your email and website usage information with other information we have about you. If you are a Mayo Clinic patient, this could include protected health information. If we combine this information with your protected health information, we will treat all of that information as protected health information and will only use or disclose that information as set forth in our notice of privacy practices. You may opt-out of email communications at any time by clicking on the unsubscribe link in the e-mail.


Hemochromatosis is most often caused by a change in a gene. This gene controls the amount of iron your body absorbs from food. The altered gene is passed from parents to children. This type of hemochromatosis is by far the most common type. It's called hereditary hemochromatosis.

Gene mutations that cause hemochromatosis

A gene called HFE is most often the cause of hereditary hemochromatosis. You inherit one HFE gene from each of your parents. The HFE gene has two common mutations, C282Y and H63D. Genetic testing can reveal whether you have these changes in your HFE gene.

  • If you inherit two altered genes, you may develop hemochromatosis. You also can pass the altered gene on to your children. But not everyone who inherits two genes develops problems linked to the iron overload of hemochromatosis.
  • If you inherit one altered gene, you're unlikely to develop hemochromatosis. However, you are considered a carrier of the mutation [altered gene] and can pass the altered gene on to your children. But your children wouldn't develop the disease unless they also inherited another altered gene from the other parent.

How hemochromatosis affects your organs

Iron plays an essential role in several body functions, including helping produce blood. But too much iron is toxic.

A hormone secreted by the liver, called hepcidin, controls how iron is used and absorbed in the body. It also controls how excess iron is stored in various organs. In hemochromatosis, the role of hepcidin is affected, causing the body to absorb more iron than it needs.

This excess iron is stored in major organs, especially the liver. Over a period of years, the stored iron can cause severe damage that may lead to organ failure. It also can lead to long-lasting diseases, such as cirrhosis, diabetes and heart failure. Many people have gene changes that cause hemochromatosis. However, not everyone develops iron overload to a degree that causes tissue and organ damage.

Hereditary hemochromatosis isn't the only type of hemochromatosis. Other types include:

  • Juvenile hemochromatosis. This causes the same problems in young people that hereditary hemochromatosis causes in adults. But iron buildup begins much earlier, and symptoms usually appear between the ages of 15 and 30. This disorder is caused by changes in the hemojuvelin or hepcidin genes.
  • Neonatal hemochromatosis. In this severe disorder, iron builds up rapidly in the liver of the developing baby in the womb. It is thought to be an autoimmune disease, in which the body attacks itself.
  • Secondary hemochromatosis.This form of the disease is not inherited and is often referred to as iron overload. People with certain types of anemia or liver disease may often need multiple blood transfusions. This can lead to excess iron buildup.

Risk factors

Factors that increase your risk of hemochromatosis include:

  • Having two copies of an altered HFE gene. This is the greatest risk factor for hereditary hemochromatosis.
  • Family history. If you have a parent or sibling with hemochromatosis, you're more likely to develop the disease.
  • Ethnicity. People of Northern European descent are more prone to hereditary hemochromatosis than are people of other ethnic backgrounds. Hemochromatosis is less common in people of Black, Hispanic and Asian ancestry.
  • Your sex. Men are more likely than women to develop symptoms of hemochromatosis at an earlier age. Because women lose iron through menstruation and pregnancy, they tend to store less of the mineral than men do. After menopause or a hysterectomy, the risk increases for women.


Untreated, hemochromatosis can lead to a number of complications. These complications especially affect your joints and organs where excess iron tends to be stored, such as your liver, pancreas and heart. Complications can include:

  • Liver problems. Cirrhosis — permanent scarring of the liver — is just one of the problems that may occur. Cirrhosis increases your risk of liver cancer and other life-threatening complications.
  • Diabetes. Damage to the pancreas can lead to diabetes.
  • Heart problems. Excess iron in your heart affects the heart's ability to circulate enough blood for your body's needs. This is called congestive heart failure. Hemochromatosis also can cause abnormal heart rhythms, called arrhythmias.
  • Reproductive problems. Excess iron can lead to erectile dysfunction and loss of sex drive in men. It can cause an absence of the menstrual cycle in women.
  • Skin color changes. Deposits of iron in skin cells can make your skin appear bronze or gray in color.

The Mayo Clinic experience and patient stories

Our patients tell us that the quality of their interactions, our attention to detail and the efficiency of their visits mean health care like they've never experienced. See the stories of satisfied Mayo Clinic patients.

Jan. 06, 2023

Living with hemochromatosis?

Connect with others like you for support and answers to your questions in the Transplants support group on Mayo Clinic Connect, a patient community.

Transplants Discussions

See more discussions
  1. Feldman M, et al., eds. Hemochromatosis. In: Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology, Diagnosis, Management. 11th ed. Elsevier; 2021.https://www.clinicalkey.com. Accessed Nov. 19, 2020.
  2. Ferri FF. Hemochromatosis. In: Ferri's Clinical Advisor 2021. Elsevier; 2021. https://www.clinicalkey.com. Accessed Nov. 19, 2020.
  3. Hemochromatosis. National Institute of Diabetes and Digestive and Kidney Diseases. https://www.niddk.nih.gov/health-information/liver-disease/hemochromatosis. Accessed Nov. 29, 2022.
  4. Torbenson MS, et al. Hemochromatosis. Mayo Clinic Proceedings. 2022; doi:10.1016/j.mayocp.2021.12.008.
  5. Kellerman RD, et al. Hemochromatosis. In: Conn's Current Therapy 2020. Elsevier; 2020. https://www.clinicalkey.com. Accessed Nov. 19, 2020.
  6. Rajan E (expert opinion). Mayo Clinic. Dec. 6, 2020.


Associated Procedures

Products & Services